Literature DB >> 28918510

Acquired hepatocerebral degeneration (AHD): a peculiar neurological impairment in advanced chronic liver disease.

A Pigoni1, F Iuculano2, C Saetti3, L Airaghi1, L Burdick1, S Spreafico1, M Curioni1, R Lombardi1, L Valenti1, A L Fracanzani1, S Fargion1.   

Abstract

We discuss the case of a rare and often unrecognized neurologic syndrome, called Acquired Hepatocerebral Degeneration (AHD), observed in patients with advanced liver disease and portosystemic shunts. The clinical manifestations can be very heterogeneous and in our case included a combination of cerebellar and extrapyramidal signs, arisen in a period of few days. Brain Magnetic Resonance Imaging (MRI) showed, in T1-weighted images, diffuse bilateral hyper intensities in basal ganglia and biemispheric brain and cerebellar cortices, resembling paramagnetic deposits. No other neurological impairments, like stroke, infection or neoplasia, were found. It was excluded an episode of acute hepatic encephalopathy. We also ruled out Wilsonian degeneration, iron overload and autoimmune encephalitis and we lastly found high manganese levels as the possible cause of the brain paramagnetic deposits. Even though either serum Mn determination or its accumulation in the brain are not specific for AHD, however the chronic and progressively worsening of the neurological manifestations advocated a degenerative condition, possibly AHD. We finally opted for the early restoration of liver function by OLT, and we observed complete clinical symptoms' resolution and partial MRI reversal after a follow up of 6 months.

Entities:  

Keywords:  Acquired hepatocerebral degeneration; Cirrhosis; Hepatic encephalopathy; Liver transplant; Manganese; Portosystemic shunts

Mesh:

Year:  2017        PMID: 28918510     DOI: 10.1007/s11011-017-0107-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  16 in total

1.  Reversal of acquired hepatocerebral degeneration with living donor liver transplantation.

Authors:  Ahmed Hassaan Qavi; Sahla Hammad; Atif I Rana; Mohammad Salih; Najmul Hassan Shah; Faisal S Dar; Arsalan Ahmad
Journal:  Liver Transpl       Date:  2015-12-09       Impact factor: 5.799

2.  Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.

Authors:  Vladimir Miletić; David Ozretić; Maja Relja
Journal:  Metab Brain Dis       Date:  2014-01-05       Impact factor: 3.584

3.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

4.  Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity.

Authors:  K J Klos; J E Ahlskog; N Kumar; S Cambern; J Butz; M Burritt; R D Fealey; C T Cowl; J E Parisi; K A Josephs
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

5.  Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients.

Authors:  Elisa Maffeo; Anna Montuschi; Guido Stura; Maria Teresa Giordana
Journal:  Neurol Sci       Date:  2013-05-28       Impact factor: 3.307

6.  Clinical and neuroradiological improvement in chronic acquired hepatocerebral degeneration after branched-chain amino acid therapy.

Authors:  Y Ueki; E Isozaki; Y Miyazaki; R Koide; T Shimizu; K Yagi; S Hirai
Journal:  Acta Neurol Scand       Date:  2002-08       Impact factor: 3.209

7.  [A case of portal-systemic shunt with progressive ataxia].

Authors:  H Nagura; H Yamanouchi
Journal:  Rinsho Shinkeigaku       Date:  1993-03

8.  Cognitive functioning in chronic acquired hepatocerebral degeneration.

Authors:  Andrea Stracciari; Katia Mattarozzi; Roberto D'Alessandro; Elisa Baldin; Maria Guarino
Journal:  Metab Brain Dis       Date:  2008-04-24       Impact factor: 3.584

9.  Acquired hepatocerebral degeneration.

Authors:  Pushpendra Nath Renjen; Laxmi Khanna; Ruchi Rastogi; Nadeem Israr Khan
Journal:  BMJ Case Rep       Date:  2013-06-18

10.  Acquired hepatocerebral degeneration.

Authors:  Destina Yalcin; Emel Oguz-Akarsu; Mehmet Sokmen
Journal:  Neurosciences (Riyadh)       Date:  2016-04       Impact factor: 0.906

View more
  2 in total

1.  Antibody-negative autoimmune encephalitis as a complication of long-term immune-suppression for liver transplantation.

Authors:  Jeffrey Spindel; Matthew Heckroth; Luis Marsano
Journal:  BMJ Case Rep       Date:  2020-09-15

Review 2.  Review of Hereditary and Acquired Rare Choreas.

Authors:  Daniel Martinez-Ramirez; Ruth H Walker; Mayela Rodríguez-Violante; Emilia M Gatto
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.